NPF Submits Letter in Support of Oregon Utiliziation Management Reform


The NPF is the leading patient advocacy group for more than 8.3 million Americans and the more than 105,000 Oregon residents living with psoriasis and psoriatic arthritis. I write to you today to express our support for HB 2517.

It is critical that patients can receive an exception to the required step therapy practice when the plan directed medication is inappropriate. Delays in treatment can have devastating health implications that are avoidable when patients have access to a timely, clear, and accessible exception request process. A recent study showsthat step therapy protocolsare inconsistent across payers, creating additional confusion and frustration for patients and their providers acting on their behalf. HB 2517would set a standard for the exception request process including timelines, clinical review criteria,and making the exception process transparent and straightforward.

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2021 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.